Zhao-zhong Su
- Oncology top 10%
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 2
- Biotechnology top 10%
- Cancer Research and Treatments 3
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 4
- Genetics top 10%
- Virus-based gene therapy research 8
-
- RNA Interference and Gene Delivery 3
-
- Autophagy in Disease and Therapy 2
-
- Endoplasmic Reticulum Stress and Disease 2
Zhao-zhong Su
14 papers receiving 855 citations
Peers
Comparison fields: 5 of 79
- Oncology 340
- Biotechnology 81
- Pathology and Forensic Medicine 168
- Genetics 247
- Cancer Research 115
Countries citing papers authored by Zhao-zhong Su
This map shows the geographic impact of Zhao-zhong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao-zhong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao-zhong Su more than expected).
Fields of papers citing papers by Zhao-zhong Su
This network shows the impact of papers produced by Zhao-zhong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao-zhong Su. The network helps show where Zhao-zhong Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhao-zhong Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 49 | |
| 2 | 2011 | 36 | |
| 3 | 2011 | 14 | |
| 4 | Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic. | 2011 | 23 |
| 5 | 2010 | 105 | |
| 6 | 2010 | 102 | |
| 7 | 2010 | 65 | |
| 8 | 2010 | 50 | |
| 9 | 2010 | 98 | |
| 10 | 2010 | 78 | |
| 11 | 2008 | 36 | |
| 12 | 2008 | 26 | |
| 13 | 2005 | 124 | |
| 14 | 2005 | 64 |
About Zhao-zhong Su
Zhao-zhong Su is a scholar working on Biotechnology, Genetics, Pathology and Forensic Medicine, Oncology and Cell Biology, having authored 14 papers that have together received 870 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Cancer Mechanisms and Therapy (4 papers), CAR-T cell therapy research (4 papers), Cancer Research and Treatments (3 papers), RNA Interference and Gene Delivery (3 papers), Autophagy in Disease and Therapy (2 papers), Peptidase Inhibition and Analysis (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Oncology (340 citations), Biotechnology (81 citations), Pathology and Forensic Medicine (168 citations), Genetics (247 citations) and Cancer Research (115 citations). Zhao-zhong Su has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Paul B. Fisher, Devanand Sarkar, Sujit K. Bhutia, Belal Azab, Swadesh K. Das, Seok‐Geun Lee, Paul Dent, Irina V. Lebedeva, Luni Emdad and Rupesh Dash. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Autophagy, Molecular Cancer Therapeutics and Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.